节律性低剂量地西他滨和维妥乐治疗慢性髓单细胞白血病是安全的，并能减少单核细胞负担。

IF 8.2 1区医学 Q1 HEMATOLOGY

Haematologica Pub Date : 2025-07-17 DOI:10.3324/haematol.2024.287253

Bradley Rockwell,Mendel Goldfinger,Ioannis Mantzaris,Aditi Shastri,Yogen Saunthararajah,Kira Gritsman,Alejandro R Sica,Noah Kornblum,Nishi Shah,David Levitz,Lauren C Shapiro,Ridhi Gupta,Anne Munoz,Aradhika Dhawan,Karen Fehn,Monica Comas,Jhannine Verceles,Dennis L Cooper,Marina Konopleva,Eric J Feldman,Amit Verma

引用次数: 0

摘要

不可用。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Metronomic low-dose regimen of decitabine and venetoclax is safe and reduces monocyte burden in chronic myelomonocytic leukemia.

Not available.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Haematologica 医学-血液学

CiteScore

14.10

自引率

2.00%

发文量

349

审稿时长

3-6 weeks

期刊介绍： Haematologica is a journal that publishes articles within the broad field of hematology. It reports on novel findings in basic, clinical, and translational research. Scope: The scope of the journal includes reporting novel research results that: Have a significant impact on understanding normal hematology or the development of hematological diseases. Are likely to bring important changes to the diagnosis or treatment of hematological diseases.